Emicizumab Safe, Effective, in Infants With Hemophilia A

(MedPage Today) -- SAN DIEGO -- Administering emicizumab (Hemlibra) to previously untreated or minimally treated infants with severe hemophilia A without factor VIII inhibitors is effective and safe, according to results from research presented...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news